NAMPT and ovarian carcinoma: As such, co-targeting CD73 was shown to potentiate nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in NAD+ biosynthesis, in a murine model of ovarian cancer [120].